Patients with Suspected Sleep Disorders
Conditions
Interventions
None listed
Sponsors
National Center of Neurology and Psychiatry
D'
isum Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants will include individuals who undergo PSG testing at our hospital from the research start date (December 1st, 2024 planning) until March 31, 2026, and who have not indicated refusal for the use or provision of their medical information for this research purpose. Note that minors will not be included in this study.
Exclusion criteria
Exclusion criteria: Individuals who have indicated refusal for the use or provision of their medical information, and those deemed ineligible by the principal investigator or co-investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Screening capability for mild or more severe SAS cases analyzed using the SAS'Eye algorithm 2 AHI more than or equal 5 indicating mild or more severe SAS detected through analysis using Sleepware G3 which is automated analysis software by Philips from measurements taken by polysomnography. Evaluate the concordance between 1 and 2. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 SAS events which are OSA, CSA, and Hypopnea detected by the SAS'Eye algorithm 2 SAS events which are OSA, CSA, and Hypopnea detected through analysis using Sleepware G3 which is automated analysis software by Philips from measurements taken by PSG Evaluate the concordance between 1 and 2 | — |
Countries
Japan
Contacts
Public ContactTomohiro Utsumi
National Center of Neurology and Psychiatry Department of Sleep-Wake Disorders, National Institute of Mental Health
Outcome results
None listed